60 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
6919
NT$99.701.6%-24.8%NT$155.2bNT$240.004079.2119.9%n/aPharmaceuticals & Biotech
6472
NT$439.506.7%-33.3%NT$56.0bNT$700.8633.365.6%2.3%Pharmaceuticals & Biotech
1795
NT$199.509.0%-9.9%NT$52.4bNT$367.0013.627.7%1.3%Pharmaceuticals & Biotech
4123
NT$39.656.6%13.1%NT$29.6bn/a2.8n/a4.4%Pharmaceuticals & Biotech
4728
New
NT$377.50-1.8%-3.8%NT$20.6bn/a28.4n/a3.2%Pharmaceuticals & Biotech
4105
NT$77.904.4%3.2%NT$19.4bNT$92.0012.0n/a5.8%Pharmaceuticals & Biotech
6620
New
NT$102.509.4%26.9%NT$17.1bNT$100.0021.96.9%2.0%Pharmaceuticals & Biotech
3705
NT$54.401.3%-9.0%NT$14.5bn/a18.3n/a5.5%Pharmaceuticals & Biotech
6550
NT$13.709.6%-64.7%NT$11.8bn/a170.1n/an/aPharmaceuticals & Biotech
1720
NT$63.901.9%11.7%NT$11.4bn/a11.8n/a3.1%Pharmaceuticals & Biotech
4162
NT$63.7010.0%-16.2%NT$9.2bn/a21.7n/a3.1%Pharmaceuticals & Biotech
6976
NT$13.251.5%-18.0%NT$7.7bn/a41745.9n/an/aPharmaceuticals & Biotech
4142
NT$17.806.0%7.9%NT$7.5bn/a5.3n/a0%Pharmaceuticals & Biotech
4746
NT$54.407.1%-19.9%NT$6.5bn/a19.3n/a5.5%Pharmaceuticals & Biotech
1734
NT$33.605.0%7.9%NT$6.4bn/a19.5n/a3.0%Pharmaceuticals & Biotech
4166
NT$25.401.8%-29.7%NT$5.7bn/a28.8n/an/aPharmaceuticals & Biotech
4726
NT$26.5510.6%-30.5%NT$5.5bn/a6.7n/an/aPharmaceuticals & Biotech
3716
NT$35.001.0%-3.7%NT$5.1bn/a13.5n/a2.9%Pharmaceuticals & Biotech
3176
NT$35.358.6%15.3%NT$4.9bn/a3.7n/an/aPharmaceuticals & Biotech
6875
NT$37.401.1%-10.5%NT$4.8bn/a70.0n/an/aPharmaceuticals & Biotech
1799
NT$33.5010.9%-33.8%NT$4.2bn/a6.1n/an/aPharmaceuticals & Biotech
7876
NT$38.004.4%n/aNT$4.1bn/a2.9n/an/aPharmaceuticals & Biotech
4120
NT$45.551.3%-19.2%NT$4.0bn/a0.9n/a8.8%Pharmaceuticals & Biotech
4174
NT$29.9512.8%-55.0%NT$3.9bn/a79.3n/an/aPharmaceuticals & Biotech
Page 1 of 2